Deal Announcements

b3 bio Reports New Venture Capital Financing

Monday, November 01, 2010 5:35:00 AM PDT | VentureDeal Staff

Research Triangle Park, North Carolina  --  Biotechnology startup company b3 bio (no website) has secured $5.7 million in new venture capital investment according to an SEC regulatory filing.

b3 bio is currently in stealth mode and is developing unpublicized biotechnologies.  The company's cofounders are Robert Bonczek and Dani Bolognesi.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1